- Email: [email protected]
Introduction: 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit
Introduction: 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit Scott J. Swanson, MD Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital, Boston, Massachusetts
he proceedings from the 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit held at The Joseph B. Martin Conference Center at Harvard Medical School on Oct 9th and 10th, 2009, and organized by Cine-Med, are presented in the accompanying supplement to The Annals of Thoracic Surgery. This summit is the second to bring together a group of international thoracic surgeons dedicated to the field of minimally invasive general thoracic surgery. The goal was to present the current state-of-the-art and give insights and data based on the faculty’s experience and to suggest where the field is heading. We were encouraged by the robust registration of over 200 attendees and feel that this is an important addition to our ongoing thoracic surgical curriculum. The papers that follow discuss a range of topics mirroring the course agenda. We begin with lung cancer detection and analysis highlighting the emerging endobronchial and endoesophageal ultrasound technology that is rapidly transforming our ability to less invasively detect nodal disease and compare this to the gold standard of mediastinoscopy. We also provide a very stimulating look at the field of cancer stem cell biology and how it might be applied to the clinical arena. Following this, the latest data related to video-assisted lung cancer surgery is reviewed including papers describing bigger (pneumonectomy) and smaller (segmentectomy) resections. We also present provocative data showing the superiority of the VATS technique in terms of clinical and biologic outcome. Last in the lung cancer session, we take a look at perspectives on minimally invasive lung cancer
T
Presented at the 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit, Boston, MA, October 9 –10, 2009. Address correspondence to Dr Swanson, Director, Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115; e-mail: [email protected].
surgery from around the world as well as comparing VATS to other technologies such as stereotactic radiosurgery and ablative techniques. Next we move to the center of the chest and review minimally invasive techniques used to treat mediastinal disease such as myasthenia gravis and how they can be applied to less common areas such as the chest wall and the diaphragm. Minimally invasive treatment of esophageal disease is highlighted in the next series of papers including one of the most exciting techniques that may revolutionize the treatment of Barrett’s dysplasia, complete endomucosal resection using a rigid esophagoscope. At the conclusion of this section following the manuscripts detailing the excellent outcomes of minimally invasive esophageal repair of giant paraesophageal hernias and re-operation for recurrent gastroesophageal reflux is a paper that any student of thoracic surgery will be thrilled to read, “Surgical Therapy for Esophageal Disease: Lessons from a Master,” by Dr F. Griffith Pearson. Finally the supplement concludes with a paper that reviews the state of the art of stent therapy and one that overviews the exciting new field of thoracic nanotechnology. I would like to thank our generous sponsors, without whom this outstanding forum would not be possible. Our platinum sponsor, Ethicon Endosurgery and our gold sponsor Covidien were the anchors and were joined by Atrium, Cardinal Health, Carefusion, Gore, Iflow, Olympus, Scanlan, Superdimension and Wexler in providing the resources necessary to make this happen. We are very proud of this meeting and the supplement emanating from it as it captures the meeting’s intellectual essence. Dr Swanson discloses that he has a financial relationship with Ethicon Endosurgery and Covidien.
SUPPLEMENT © 2010 by The Society of Thoracic Surgeons Published by Elsevier Inc
Ann Thorac Surg 2010;89:S2078 • 0003-4975/$36.00 doi:10.1016/j.athoracsur.2010.04.088
he proceedings from the 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit held at The Joseph B. Martin Conference Center at Harvard Medical School on Oct 9th and 10th, 2009, and organized by Cine-Med, are presented in the accompanying supplement to The Annals of Thoracic Surgery. This summit is the second to bring together a group of international thoracic surgeons dedicated to the field of minimally invasive general thoracic surgery. The goal was to present the current state-of-the-art and give insights and data based on the faculty’s experience and to suggest where the field is heading. We were encouraged by the robust registration of over 200 attendees and feel that this is an important addition to our ongoing thoracic surgical curriculum. The papers that follow discuss a range of topics mirroring the course agenda. We begin with lung cancer detection and analysis highlighting the emerging endobronchial and endoesophageal ultrasound technology that is rapidly transforming our ability to less invasively detect nodal disease and compare this to the gold standard of mediastinoscopy. We also provide a very stimulating look at the field of cancer stem cell biology and how it might be applied to the clinical arena. Following this, the latest data related to video-assisted lung cancer surgery is reviewed including papers describing bigger (pneumonectomy) and smaller (segmentectomy) resections. We also present provocative data showing the superiority of the VATS technique in terms of clinical and biologic outcome. Last in the lung cancer session, we take a look at perspectives on minimally invasive lung cancer
T
Presented at the 2nd International Bi-Annual Minimally Invasive Thoracic Surgery Summit, Boston, MA, October 9 –10, 2009. Address correspondence to Dr Swanson, Director, Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115; e-mail: [email protected].
surgery from around the world as well as comparing VATS to other technologies such as stereotactic radiosurgery and ablative techniques. Next we move to the center of the chest and review minimally invasive techniques used to treat mediastinal disease such as myasthenia gravis and how they can be applied to less common areas such as the chest wall and the diaphragm. Minimally invasive treatment of esophageal disease is highlighted in the next series of papers including one of the most exciting techniques that may revolutionize the treatment of Barrett’s dysplasia, complete endomucosal resection using a rigid esophagoscope. At the conclusion of this section following the manuscripts detailing the excellent outcomes of minimally invasive esophageal repair of giant paraesophageal hernias and re-operation for recurrent gastroesophageal reflux is a paper that any student of thoracic surgery will be thrilled to read, “Surgical Therapy for Esophageal Disease: Lessons from a Master,” by Dr F. Griffith Pearson. Finally the supplement concludes with a paper that reviews the state of the art of stent therapy and one that overviews the exciting new field of thoracic nanotechnology. I would like to thank our generous sponsors, without whom this outstanding forum would not be possible. Our platinum sponsor, Ethicon Endosurgery and our gold sponsor Covidien were the anchors and were joined by Atrium, Cardinal Health, Carefusion, Gore, Iflow, Olympus, Scanlan, Superdimension and Wexler in providing the resources necessary to make this happen. We are very proud of this meeting and the supplement emanating from it as it captures the meeting’s intellectual essence. Dr Swanson discloses that he has a financial relationship with Ethicon Endosurgery and Covidien.
SUPPLEMENT © 2010 by The Society of Thoracic Surgeons Published by Elsevier Inc
Ann Thorac Surg 2010;89:S2078 • 0003-4975/$36.00 doi:10.1016/j.athoracsur.2010.04.088